Artiva Biotherapeutics, Inc.

Follow

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY
- Publication number 20240197778
- Publication date Jun 20, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240180962
- Publication date Jun 6, 2024
- Artiva Biotherapeutics, Inc.
- Sungyoo CHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY
- Publication number 20240115704
- Publication date Apr 11, 2024
- Artiva Biotherapeutics, Inc.
- Peter FLYNN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPANDED AND STIMULATED NATURAL KILLER CELLS
- Publication number 20240060046
- Publication date Feb 22, 2024
- Artiva Biotherapeutics, Inc.
- Seungryel Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240000840
- Publication date Jan 4, 2024
- Artiva Biotherapeutics, Inc.
- Yu Kyeong Hwang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
90559007 - ALLONK
- Serial number 90559007
- Registration number 7056075
- Filing date Mar 4, 2021
- Artiva Biotherapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations